Skip to main content
Erschienen in: Environmental Health and Preventive Medicine 4/2010

01.07.2010 | Regular Article

Abdominal circumference should not be a required criterion for the diagnosis of metabolic syndrome

verfasst von: Kiyoshi Shibata, Sadao Suzuki, Juichi Sato, Isao Ohsawa, Shinichi Goto, Masaru Hashiguchi, Shinkan Tokudome

Erschienen in: Environmental Health and Preventive Medicine | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Metabolic syndrome (MetS) is an established concept. However, it is characterized by a number of different definitions as well as different cut-off points (COPs) for waist circumference (WC) and different modes for incorporating WC into the diagnostic criteria.

Methods

Abdominal ultrasonography was performed in 2,333 subjects who also underwent comprehensive medical examinations between April and July 2006. The odds ratios for the number of MetS components were calculated by taking central obesity status into account and considering concurrent fatty liver as an independent variable. We compared the areas under the receiver operating characteristic (ROC) curves for fatty liver and MetS using several MetS criteria.

Results

Regardless of the WC criterion selected, we observed a strong linear trend for an association (trend P < 0.0001) between MetS and the number of components. The odds ratio (OR) of subjects without central obesity but with all three MetS components was 9.69 (95% confidence interval 3.11–30.2) in men and 55.3 (6.34–483) in women. The COP for the largest area under the curve in men and women was ≥82 cm (OR 0.701) and ≥77 cm (OR 0.699), respectively, when WC was considered as a component. When WC distribution is taken into consideration, practical and appropriate COPs should be ≥85 cm for men and ≥80 cm for women.

Conclusion

We suggest that a WC of ≥85 cm for men and ≥80 cm for women would be optimal COPs for the central obesity criteria in the Japanese population. In addition, central obesity should be incorporated as a component of MetS rather than an essential requirement for the diagnosis of MetS.
Literatur
1.
Zurück zum Zitat Matsuzawa Y. Definition and history of metabolic syndrome (in Japanese). Nippon Rinsho. 2006;64:9–12.PubMed Matsuzawa Y. Definition and history of metabolic syndrome (in Japanese). Nippon Rinsho. 2006;64:9–12.PubMed
2.
Zurück zum Zitat Wlodarczyk A, Strojek K. Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. Obesity predicts coronary atherosclerosis and dysglycemia. Pol Arch Med Wewn. 2008;118:719–26.PubMed Wlodarczyk A, Strojek K. Glucose intolerance, insulin resistance and metabolic syndrome in patients with stable angina pectoris. Obesity predicts coronary atherosclerosis and dysglycemia. Pol Arch Med Wewn. 2008;118:719–26.PubMed
3.
Zurück zum Zitat Bulugahapitiya U, Siyambalapitiya S, Sithole J, et al. The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study. Diab Vasc Dis Res. 2009;6:21–4.CrossRefPubMed Bulugahapitiya U, Siyambalapitiya S, Sithole J, et al. The clinical impact of identifying metabolic syndrome in patients with diabetes: a cross-sectional study. Diab Vasc Dis Res. 2009;6:21–4.CrossRefPubMed
4.
Zurück zum Zitat Ford ES, Schulze MB, Pischon T, et al. Metabolic syndrome and risk of incident diabetes: findings from the European prospective investigation into cancer and nutrition-potsdam study. Cardiovasc Diabetol. 2008;7:35.CrossRefPubMed Ford ES, Schulze MB, Pischon T, et al. Metabolic syndrome and risk of incident diabetes: findings from the European prospective investigation into cancer and nutrition-potsdam study. Cardiovasc Diabetol. 2008;7:35.CrossRefPubMed
5.
Zurück zum Zitat Wannamethee SG, Shaper AG, Lennon L, et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644–50.CrossRefPubMed Wannamethee SG, Shaper AG, Lennon L, et al. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644–50.CrossRefPubMed
6.
Zurück zum Zitat McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–90.CrossRefPubMed McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–90.CrossRefPubMed
7.
Zurück zum Zitat Kanauchi M, Kanauchi K, Hashimoto T, et al. Metabolic syndrome and new category ‘pre-hypertension’ in a Japanese population. Curr Med Res Opin. 2004;20(9):1365–70.CrossRefPubMed Kanauchi M, Kanauchi K, Hashimoto T, et al. Metabolic syndrome and new category ‘pre-hypertension’ in a Japanese population. Curr Med Res Opin. 2004;20(9):1365–70.CrossRefPubMed
8.
Zurück zum Zitat Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–50.CrossRefPubMed Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110:1245–50.CrossRefPubMed
9.
10.
Zurück zum Zitat Lindsay RS, Wake DJ, Nair S, et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 2003;88:2738–44.CrossRefPubMed Lindsay RS, Wake DJ, Nair S, et al. Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab. 2003;88:2738–44.CrossRefPubMed
11.
Zurück zum Zitat Itoh H. What is ‘metabolic domino effect’?––new concept in lifestyle-related disease (in Japanese). Nippon Rinsho. 2003;61:1837–43.PubMed Itoh H. What is ‘metabolic domino effect’?––new concept in lifestyle-related disease (in Japanese). Nippon Rinsho. 2003;61:1837–43.PubMed
12.
Zurück zum Zitat Itoh H. Metabolic domino: new concept in lifestyle medicine. Drugs Today. 2006;42:9–16.PubMed Itoh H. Metabolic domino: new concept in lifestyle medicine. Drugs Today. 2006;42:9–16.PubMed
13.
Zurück zum Zitat World Health Organization. Definition, diagnosis classification of diabetes mellitus, its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999. World Health Organization. Definition, diagnosis classification of diabetes mellitus, its complications. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
14.
Zurück zum Zitat Expert panel on detection, evaluation, treatment of high blood cholesterol in adults. Executive summary of the third report of national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA. 2001;285:2486–97.CrossRef Expert panel on detection, evaluation, treatment of high blood cholesterol in adults. Executive summary of the third report of national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA. 2001;285:2486–97.CrossRef
15.
Zurück zum Zitat Alberti KG, Zimmet P, Shaw J. International diabetes federation: a consensus on Type 2 diabetes prevention. Diabetes Med. 2007;24:451–63.CrossRef Alberti KG, Zimmet P, Shaw J. International diabetes federation: a consensus on Type 2 diabetes prevention. Diabetes Med. 2007;24:451–63.CrossRef
16.
Zurück zum Zitat The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome (in Japanese). J Jpn Soc Intern Med. 2005;94:794–809. The Examination Committee for Criteria of Metabolic Syndrome. Definition and criteria of metabolic syndrome (in Japanese). J Jpn Soc Intern Med. 2005;94:794–809.
17.
Zurück zum Zitat Taylor KJ, Carpenter DA, Hill CR, et al. Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology. 1976;119:415–23.PubMed Taylor KJ, Carpenter DA, Hill CR, et al. Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology. 1976;119:415–23.PubMed
18.
Zurück zum Zitat Joseph AE, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the “bright liver”). Br J Radiol. 1979;52:184–8.CrossRefPubMed Joseph AE, Dewbury KC, McGuire PG. Ultrasound in the detection of chronic liver disease (the “bright liver”). Br J Radiol. 1979;52:184–8.CrossRefPubMed
19.
Zurück zum Zitat Kurtz AB, Dubbins PA, Rubin CS, et al. Echogenicity: analysis, significance, and masking. Am J Roentgenol. 1981;137:471–6. Kurtz AB, Dubbins PA, Rubin CS, et al. Echogenicity: analysis, significance, and masking. Am J Roentgenol. 1981;137:471–6.
20.
Zurück zum Zitat Yajima Y, Ohta K, Narui T, et al. Ultrasound in the diagnosis of diffuse liver disease (in Japanese). Rinsho Hoshasen. 1982;27:553–7.PubMed Yajima Y, Ohta K, Narui T, et al. Ultrasound in the diagnosis of diffuse liver disease (in Japanese). Rinsho Hoshasen. 1982;27:553–7.PubMed
21.
Zurück zum Zitat Oda E, Abe M, Veeraveedu PT, et al. Considerable disagreement among definitions of metabolic syndrome for Japanese. Circ J. 2007;71:1239–43.CrossRefPubMed Oda E, Abe M, Veeraveedu PT, et al. Considerable disagreement among definitions of metabolic syndrome for Japanese. Circ J. 2007;71:1239–43.CrossRefPubMed
22.
Zurück zum Zitat Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract. 2008;79:474–81.PubMed Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract. 2008;79:474–81.PubMed
23.
Zurück zum Zitat Baik I. Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation. Circ J. 2009;73:2068–75.CrossRefPubMed Baik I. Optimal cutoff points of waist circumference for the criteria of abdominal obesity: comparison with the criteria of the International Diabetes Federation. Circ J. 2009;73:2068–75.CrossRefPubMed
24.
Zurück zum Zitat Sato A, Asayama K, Ohkubo T, et al. Optimal cutoff point of waist circumference and use of home blood pressure as a definition of metabolic syndrome: the Ohasama study. Am J Hypertens. 2008;21:514–20.CrossRefPubMed Sato A, Asayama K, Ohkubo T, et al. Optimal cutoff point of waist circumference and use of home blood pressure as a definition of metabolic syndrome: the Ohasama study. Am J Hypertens. 2008;21:514–20.CrossRefPubMed
25.
Zurück zum Zitat Hara K, Matsushita Y, Horikoshi M, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2006;29:1123–4.CrossRefPubMed Hara K, Matsushita Y, Horikoshi M, et al. A proposal for the cutoff point of waist circumference for the diagnosis of metabolic syndrome in the Japanese population. Diabetes Care. 2006;29:1123–4.CrossRefPubMed
26.
Zurück zum Zitat Kadota A, Hozawa A, Okamura T, et al. NIPPON DATA Research Group. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990–2000. Diabetes Care. 2007;30:1533–8.CrossRefPubMed Kadota A, Hozawa A, Okamura T, et al. NIPPON DATA Research Group. Relationship between metabolic risk factor clustering and cardiovascular mortality stratified by high blood glucose and obesity: NIPPON DATA90, 1990–2000. Diabetes Care. 2007;30:1533–8.CrossRefPubMed
27.
Zurück zum Zitat Doi Y, Ninomiya T, Hata J, et al. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke. 2009;40:1187–94.CrossRefPubMed Doi Y, Ninomiya T, Hata J, et al. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study. Stroke. 2009;40:1187–94.CrossRefPubMed
Metadaten
Titel
Abdominal circumference should not be a required criterion for the diagnosis of metabolic syndrome
verfasst von
Kiyoshi Shibata
Sadao Suzuki
Juichi Sato
Isao Ohsawa
Shinichi Goto
Masaru Hashiguchi
Shinkan Tokudome
Publikationsdatum
01.07.2010
Verlag
Springer Japan
Erschienen in
Environmental Health and Preventive Medicine / Ausgabe 4/2010
Print ISSN: 1342-078X
Elektronische ISSN: 1347-4715
DOI
https://doi.org/10.1007/s12199-009-0132-7

Weitere Artikel der Ausgabe 4/2010

Environmental Health and Preventive Medicine 4/2010 Zur Ausgabe